Healthcare & Life Sciences
Genalyte
United Statesgenalyte.com
Genalyte is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
4
Investors
About Genalyte
Genalyte is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Genalyte develops a fully automated, on-site blood diagnostic testing device called Merlin that delivers accurate lab results within 30 minutes directly at the point of care, integrating seamlessly with electronic medical records.
Explore Genalyte's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.